Qiuzhe Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qiuzhe Guo has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Fangbing Yan
School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products Kunming Medical University Kunming China
2 shared publicationsSha Wu
School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
2 shared publications- Weimin Yang
School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming 650500, China
2 shared publications Youlan Wang
Kunming Institute of Medical Sciences, Kunming, People’s Republic of China
2 shared publicationsCai Kong
Yunnan Population and Family Planning Research Institute, Wuhua District
1 shared publication- Chao Yang
Aalto University
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1778716
Post-treatment status and unmet treatment needs after congenital heart defect screening policy in school-aged children: a multi-ethnic screening of 1.02 million in China
Objective: This large-scale, multi-ethnic screening of over 1.02 million school-aged children in China aimed to evaluate the real-world impact of recent congenital heart disease (CHD) screening policies by determining the community-based prevalence and clinical management status. Using a novel four-category framework (needing treatment, not needing treatment, postoperative, requiring follow-up), the study sought to identify persistent unmet needs and ethnic disparities in care access following policy implementation. Methods: Between 2024–2025, a cross-sectional screening of 1,024,531 school-aged children (3–18 years) was conducted across 12 ethnically diverse counties in Yunnan, Xinjiang and Chongqing, China. All participants underwent cardiac auscultation and confirmatory echocardiography. CHD cases were classified into one of four categories: Needing treatment, not needing treatment, postoperative, and follow-up. Multi-ethnic disparities in prevalence and defect types were analyzed. Results: A total of 3,376 children were diagnosed with CHD, yielding an overall prevalence of 3.30 per 1,000. Critically, the four-category stratification revealed: 48.7% were postoperative cases, 35.5% required no intervention, 14.3% needed treatment unmet, and 1.5% required further follow-up. Notably, substantial ethnic disparities were observed: Uyghurs had the highest postoperative rate (55%), whereas the Tujia minority group had the highest proportion of untreated but treatable cases. Conclusion: The findings revealed the achievement and underscored gaps in early diagnosis and equitable access to CHD care, particularly among ethnic minorities after CHD screening and care policy implementation, advocating for improved sustainability health policies to reduce unmet CHD needs in multi-ethnic populations.
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1778716
Open AccessPost-treatment status and unmet treatment needs after congenital heart defect screening policy in school-aged children: a multi-ethnic screening of 1.02 million in China
Objective: This large-scale, multi-ethnic screening of over 1.02 million school-aged children in China aimed to evaluate the real-world impact of recent congenital heart disease (CHD) screening policies by determining the community-based prevalence and clinical management status. Using a novel four-category framework (needing treatment, not needing treatment, postoperative, requiring follow-up), the study sought to identify persistent unmet needs and ethnic disparities in care access following policy implementation. Methods: Between 2024–2025, a cross-sectional screening of 1,024,531 school-aged children (3–18 years) was conducted across 12 ethnically diverse counties in Yunnan, Xinjiang and Chongqing, China. All participants underwent cardiac auscultation and confirmatory echocardiography. CHD cases were classified into one of four categories: Needing treatment, not needing treatment, postoperative, and follow-up. Multi-ethnic disparities in prevalence and defect types were analyzed. Results: A total of 3,376 children were diagnosed with CHD, yielding an overall prevalence of 3.30 per 1,000. Critically, the four-category stratification revealed: 48.7% were postoperative cases, 35.5% required no intervention, 14.3% needed treatment unmet, and 1.5% required further follow-up. Notably, substantial ethnic disparities were observed: Uyghurs had the highest postoperative rate (55%), whereas the Tujia minority group had the highest proportion of untreated but treatable cases. Conclusion: The findings revealed the achievement and underscored gaps in early diagnosis and equitable access to CHD care, particularly among ethnic minorities after CHD screening and care policy implementation, advocating for improved sustainability health policies to reduce unmet CHD needs in multi-ethnic populations.
- Open Access
- 18 March 2026
- Published by Wiley in Echocardiography
- Vol. 43 (3) , e70419
Impact of Coronary Microvascular Dysfunction on Left Ventricular Function After Percutaneous Coronary Intervention: Assessment With Combined Dipyridamole‐Exercise Stress and Myocardial Strain/Work
Background: Coronary microvascular dysfunction (CMD) persists after percutaneous coronary intervention (PCI) in individuals with coronary artery disease (CAD). This study assessed CMD using combined dipyridamole‐exercise stress echocardiography (DExE) and myocardial strain/work to evaluate the impact on left ventricular (LV) function. Methods: This prospective study enrolled CAD individuals who underwent left anterior descending artery PCI and DExE assessment at 3 months post‐PCI to evaluate myocardial strain/work parameters at rest and stress. The primary endpoint was adverse clinical events, and the secondary endpoint was Seattle Angina Questionnaire (SAQ) health status at 1‐year. Results: The cohort comprised 84 individuals (54 ± 10 years, 17.9% female). Participants were stratified into two groups by coronary flow velocity reserve (CFVR): CFVR ≥ 2.5 group ( n = 63) and CFVR < 2.5 group ( n = 21). Compared with the CFVR ≥ 2.5 group, the CFVR < 2.5 group showed impaired LV functional reserve, with lower global longitudinal strain (GLS), global work index (GWI), and global work efficiency (GWE) at peak exercise and recovery, lower peak exercise global constructive work (GCW), higher recovery global wasted work (GWW), and smaller absolute changes ΔE—R (difference before vs. after exercise stress) in GLS, GWI, and GCW (all p < 0.05). In multivariable analysis, peak exercise GCW, recovery GWW, and ΔGCW (E − R) were independent predictors of CMD. At 1 year, no adverse clinical events occurred, and the CFVR ≥ 2.5 group had higher SAQ physical limitation (92.86 ± 11.38 vs. 82.14 ± 17.93), quality of life (95.63 ± 10.57 vs. 83.33 ± 19.90), and summary score (94.05 ± 8.51 vs. 85.71 ± 15.71) than the CFVR < 2.5 group (all p < 0.05). Conclusions: Combined DExE with myocardial strain/work analysis effectively evaluates LV function in CMD. Decreased CFVR post‐PCI is associated with impaired LV function and worse 1‐year quality of life outcomes, underscoring the need for close cardiac function monitoring in post‐PCI CMD individuals. Trial Registration: URL: https://www.chictr.org.cn/ ; Unique identifier: ChiCTR2500103229.
- 18 March 2026
- Published by Wiley in Echocardiography
- Vol. 43 (3) , e70419
Open AccessImpact of Coronary Microvascular Dysfunction on Left Ventricular Function After Percutaneous Coronary Intervention: Assessment With Combined Dipyridamole‐Exercise Stress and Myocardial Strain/Work
Background: Coronary microvascular dysfunction (CMD) persists after percutaneous coronary intervention (PCI) in individuals with coronary artery disease (CAD). This study assessed CMD using combined dipyridamole‐exercise stress echocardiography (DExE) and myocardial strain/work to evaluate the impact on left ventricular (LV) function. Methods: This prospective study enrolled CAD individuals who underwent left anterior descending artery PCI and DExE assessment at 3 months post‐PCI to evaluate myocardial strain/work parameters at rest and stress. The primary endpoint was adverse clinical events, and the secondary endpoint was Seattle Angina Questionnaire (SAQ) health status at 1‐year. Results: The cohort comprised 84 individuals (54 ± 10 years, 17.9% female). Participants were stratified into two groups by coronary flow velocity reserve (CFVR): CFVR ≥ 2.5 group ( n = 63) and CFVR < 2.5 group ( n = 21). Compared with the CFVR ≥ 2.5 group, the CFVR < 2.5 group showed impaired LV functional reserve, with lower global longitudinal strain (GLS), global work index (GWI), and global work efficiency (GWE) at peak exercise and recovery, lower peak exercise global constructive work (GCW), higher recovery global wasted work (GWW), and smaller absolute changes ΔE—R (difference before vs. after exercise stress) in GLS, GWI, and GCW (all p < 0.05). In multivariable analysis, peak exercise GCW, recovery GWW, and ΔGCW (E − R) were independent predictors of CMD. At 1 year, no adverse clinical events occurred, and the CFVR ≥ 2.5 group had higher SAQ physical limitation (92.86 ± 11.38 vs. 82.14 ± 17.93), quality of life (95.63 ± 10.57 vs. 83.33 ± 19.90), and summary score (94.05 ± 8.51 vs. 85.71 ± 15.71) than the CFVR < 2.5 group (all p < 0.05). Conclusions: Combined DExE with myocardial strain/work analysis effectively evaluates LV function in CMD. Decreased CFVR post‐PCI is associated with impaired LV function and worse 1‐year quality of life outcomes, underscoring the need for close cardiac function monitoring in post‐PCI CMD individuals. Trial Registration: URL: https://www.chictr.org.cn/ ; Unique identifier: ChiCTR2500103229.
- Open Access
- 25 January 2025
- Published by Springer Nature
- p. 3-20
Semantic-Enhanced Digital Twin for Industrial Working Environments
Real-time data from diverse Internet of Things (IoT) sensors (such as cameras, temperature, light, and air quality sensors) is essential for monitoring smart manufacturing environments. However, efficiently perceiving, integrating, and interpreting this data remains a challenge, as it involves dealing with heterogeneous data formats, ensuring data accuracy, and providing real-time analytics. This paper proposes a semantic-enhanced Digital Twin (DT) to address these complexities and aims to offer a comprehensive view of industrial working environments. The paper first presents a conceptual overview of the semantic-enhanced DT architecture, followed by a detailed description of the system architecture, encompassing edge, cloud, and interface modules. Additionally, the implementation of the entire system is presented. The results demonstrate the feasibility of the proposed DT, showing its potential for deployment in real-world scenarios.
- 25 January 2025
- Published by Springer Nature
- p. 3-20
Open AccessSemantic-Enhanced Digital Twin for Industrial Working Environments
Real-time data from diverse Internet of Things (IoT) sensors (such as cameras, temperature, light, and air quality sensors) is essential for monitoring smart manufacturing environments. However, efficiently perceiving, integrating, and interpreting this data remains a challenge, as it involves dealing with heterogeneous data formats, ensuring data accuracy, and providing real-time analytics. This paper proposes a semantic-enhanced Digital Twin (DT) to address these complexities and aims to offer a comprehensive view of industrial working environments. The paper first presents a conceptual overview of the semantic-enhanced DT architecture, followed by a detailed description of the system architecture, encompassing edge, cloud, and interface modules. Additionally, the implementation of the entire system is presented. The results demonstrate the feasibility of the proposed DT, showing its potential for deployment in real-world scenarios.
- Open Access
- 1 December 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5989-6001
Synergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models
Background: Sepsis is initiated by the dysfunctional response of the host immune system to infection. Septic shock and acute lung injury (ALI) are the main etiology of death caused by sepsis. Glucocorticoids, which are commonly used in clinic to antagonize the inflammatory response of sepsis, may cause serious side effects. Isoforskolin (ISOF) from the plant Coleus forskohlii stimulates adenylyl cyclase, increases the cAMP level and inhibits inflammatory response. The aim of this study was to investigate the synergistic effect of ISOF with dexamethasone (DEX) to prevent and ameliorate septic inflammation. Methods: Lipopolysaccharide (LPS) of 30 and 5 mg/kg (iv.) was used to induce sepsis and ALI mice model respectively in vivo. BEAS-2B cells stimulated by LPS were applied as cell model in vitro. The cumulative survival of mice with LPS-induced sepsis and the histopathological changes of lungs in mice with acute lung injury were observed, and the secretion of pro-inflammatory cytokines was analyzed by ELISA. The expression of RGS2 in BEAS-2B cells was detected by immunoblotting assay and PCR. Results: In the sepsis mice model, ISOF (10 mg/kg) combined with DEX (10 mg/kg.) (ip.) pretreatment significantly increased mice survival rate from 33.3% to 58.3%, which was significantly higher than that of ISOF or DEX treated alone. In the ALI mice model, ISOF, DEX pretreatment alone and combined application attenuated pulmonary pathological changes in ALI mice. Furthermore, ISOF, DEX alone or combined administration decreased MPO, MDA, IL-6, and IL-8 levels, while significantly synergistic effects were observed in the combined treatment group compared with ISOF or DEX alone. In BEAS-2B cells, combined pretreatment with ISOF and DEX significantly decreased the expression of IL-8 and increased the expression of RGS2. Conclusion: The results indicated that ISOF in combination with DEX synergistically improves survival rate and attenuates ALI in mice model through anti-inflammatory and antioxidant effects.
- 1 December 2023
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 16, 5989-6001
Open AccessSynergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models
Background: Sepsis is initiated by the dysfunctional response of the host immune system to infection. Septic shock and acute lung injury (ALI) are the main etiology of death caused by sepsis. Glucocorticoids, which are commonly used in clinic to antagonize the inflammatory response of sepsis, may cause serious side effects. Isoforskolin (ISOF) from the plant Coleus forskohlii stimulates adenylyl cyclase, increases the cAMP level and inhibits inflammatory response. The aim of this study was to investigate the synergistic effect of ISOF with dexamethasone (DEX) to prevent and ameliorate septic inflammation. Methods: Lipopolysaccharide (LPS) of 30 and 5 mg/kg (iv.) was used to induce sepsis and ALI mice model respectively in vivo. BEAS-2B cells stimulated by LPS were applied as cell model in vitro. The cumulative survival of mice with LPS-induced sepsis and the histopathological changes of lungs in mice with acute lung injury were observed, and the secretion of pro-inflammatory cytokines was analyzed by ELISA. The expression of RGS2 in BEAS-2B cells was detected by immunoblotting assay and PCR. Results: In the sepsis mice model, ISOF (10 mg/kg) combined with DEX (10 mg/kg.) (ip.) pretreatment significantly increased mice survival rate from 33.3% to 58.3%, which was significantly higher than that of ISOF or DEX treated alone. In the ALI mice model, ISOF, DEX pretreatment alone and combined application attenuated pulmonary pathological changes in ALI mice. Furthermore, ISOF, DEX alone or combined administration decreased MPO, MDA, IL-6, and IL-8 levels, while significantly synergistic effects were observed in the combined treatment group compared with ISOF or DEX alone. In BEAS-2B cells, combined pretreatment with ISOF and DEX significantly decreased the expression of IL-8 and increased the expression of RGS2. Conclusion: The results indicated that ISOF in combination with DEX synergistically improves survival rate and attenuates ALI in mice model through anti-inflammatory and antioxidant effects.
- Open Access
- 4 August 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-20
Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ
Objective. To reveal the molecular mechanism of the antagonistic effect of traditional Chinese medicine Tianma formula (TF) on dementia including vascular dementia (VaD) and Alzheimers disease (AD) and to provide a scientific basis for the study of traditional Chinese medicine for prevention and treatment of dementia. Method. The TF was derived from the concerted application of traditional Chinese medicine. We detected the pharmacological effect of TF in VaD rats. The molecular mechanism of TF was examined by APP/PS1 mice in vivo, Caenorhabditis elegans (C. elegans) in vitro, ELISA, pathological assay via HE staining, and transcriptome. Based on RNA-seq analysis in VaD rats, the differentially expressed genes (DEGs) were identified and then verified by quantitative PCR (qPCR) and ELISA. The molecular mechanisms of TF on dementia were further confirmed by network pharmacology and molecular docking finally. Results. The Morris water maze showed that TF could improve the cognitive memory function of the VaD rats. The ELISA and histological analysis suggested that TF could protect the hippocampus via reducing tau and IL-6 levels and increasing SYN expression. Meanwhile, it could protect the neurological function by alleviating Aβ deposition in APP/PS1 mice and C. elegans. In the RNA-seq analysis, 3 sphingolipid metabolism pathway-related genes, ADORA3, FCER1G, and ACER2, and another 5 nerve-related genes in 45 key DEGs were identified, so it indicated that the protection mechanism of TF was mainly associated with the sphingolipid metabolism pathway. In the qPCR assay, compared with the model group, the mRNA expressions of the 8 genes mentioned above were upregulated, and these results were consistent with RNA-seq. The protein and mRNA levels of ACER2 were also upregulated. Also, the results of network pharmacology analysis and molecular docking were consistent with those of RNA-seq analysis. Conclusion. TF alleviates dementia by reducing Aβ deposition via the ACER2-mediated sphingolipid signaling pathway.
- 4 August 2021
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-20
Open AccessTianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Aβ
Objective. To reveal the molecular mechanism of the antagonistic effect of traditional Chinese medicine Tianma formula (TF) on dementia including vascular dementia (VaD) and Alzheimers disease (AD) and to provide a scientific basis for the study of traditional Chinese medicine for prevention and treatment of dementia. Method. The TF was derived from the concerted application of traditional Chinese medicine. We detected the pharmacological effect of TF in VaD rats. The molecular mechanism of TF was examined by APP/PS1 mice in vivo, Caenorhabditis elegans (C. elegans) in vitro, ELISA, pathological assay via HE staining, and transcriptome. Based on RNA-seq analysis in VaD rats, the differentially expressed genes (DEGs) were identified and then verified by quantitative PCR (qPCR) and ELISA. The molecular mechanisms of TF on dementia were further confirmed by network pharmacology and molecular docking finally. Results. The Morris water maze showed that TF could improve the cognitive memory function of the VaD rats. The ELISA and histological analysis suggested that TF could protect the hippocampus via reducing tau and IL-6 levels and increasing SYN expression. Meanwhile, it could protect the neurological function by alleviating Aβ deposition in APP/PS1 mice and C. elegans. In the RNA-seq analysis, 3 sphingolipid metabolism pathway-related genes, ADORA3, FCER1G, and ACER2, and another 5 nerve-related genes in 45 key DEGs were identified, so it indicated that the protection mechanism of TF was mainly associated with the sphingolipid metabolism pathway. In the qPCR assay, compared with the model group, the mRNA expressions of the 8 genes mentioned above were upregulated, and these results were consistent with RNA-seq. The protein and mRNA levels of ACER2 were also upregulated. Also, the results of network pharmacology analysis and molecular docking were consistent with those of RNA-seq analysis. Conclusion. TF alleviates dementia by reducing Aβ deposition via the ACER2-mediated sphingolipid signaling pathway.
- 23 June 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (8) , 2316-2328
Bi‐atrial or left atrial ablation of atrial fibrillation during concomitant cardiac surgery: A Bayesian network meta‐analysis of randomized controlled trials
Objective: Surgical ablation of atrial fibrillation (AF) has become a routine procedure during concomitant cardiac surgery, however, the extension of lesion sets remain controversial. We sought to compare the relative benefit and risk of different lesion sets through a Bayesian network meta‐analysis (NMA).Methods: Pubmed, Embase, and Cochrane Trials databases were searched for randomized controlled trials (RCTs) comparing the rhythm outcome of AF patients undergoing pulmonary vein isolation (PVI), left atrial Maze (LAM), bi‐atrial Maze (BAM), or no ablation during concomitant cardiac surgery. An NMA was conducted to explore the difference of over 1 year AF freedom as well as risks for early mortality and permanent pacemaker implantation (PPMI).Results: A total of 2031 patients of 19 RCTs were included. PVI, LAM, and BAM (OR [95% Cr.I]: 5.02 [2.72, 10.02], 7.97 [4.93, 14.29], 8.29 [4.90, 14.86], p < .05) demonstrated higher freedom of AF compared with no ablation, however, no significant difference of rhythm outcome was found among the three ablation strategies based on the random‐effects model. BAM was associated with an increase in early mortality when compared with no ablation (OR [95% Cr.I]: 4.08 [1.23, 17.30], p < .05), while none of the remaining comparisons reached statistical difference in terms of early mortality and PPMI.Conclusion: Bi‐atrial ablation is not superior to left atrial ablation strategies in reducing AF recurrence for un‐selected surgical patients. BAM has a higher risk of early mortality than no ablation, but no difference was found between bi‐atrial and left atrial ablation in regard to early mortality and PPMI based on the current evidence.
- 23 June 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (8) , 2316-2328
Bi‐atrial or left atrial ablation of atrial fibrillation during concomitant cardiac surgery: A Bayesian network meta‐analysis of randomized controlled trials
Objective: Surgical ablation of atrial fibrillation (AF) has become a routine procedure during concomitant cardiac surgery, however, the extension of lesion sets remain controversial. We sought to compare the relative benefit and risk of different lesion sets through a Bayesian network meta‐analysis (NMA).Methods: Pubmed, Embase, and Cochrane Trials databases were searched for randomized controlled trials (RCTs) comparing the rhythm outcome of AF patients undergoing pulmonary vein isolation (PVI), left atrial Maze (LAM), bi‐atrial Maze (BAM), or no ablation during concomitant cardiac surgery. An NMA was conducted to explore the difference of over 1 year AF freedom as well as risks for early mortality and permanent pacemaker implantation (PPMI).Results: A total of 2031 patients of 19 RCTs were included. PVI, LAM, and BAM (OR [95% Cr.I]: 5.02 [2.72, 10.02], 7.97 [4.93, 14.29], 8.29 [4.90, 14.86], p < .05) demonstrated higher freedom of AF compared with no ablation, however, no significant difference of rhythm outcome was found among the three ablation strategies based on the random‐effects model. BAM was associated with an increase in early mortality when compared with no ablation (OR [95% Cr.I]: 4.08 [1.23, 17.30], p < .05), while none of the remaining comparisons reached statistical difference in terms of early mortality and PPMI.Conclusion: Bi‐atrial ablation is not superior to left atrial ablation strategies in reducing AF recurrence for un‐selected surgical patients. BAM has a higher risk of early mortality than no ablation, but no difference was found between bi‐atrial and left atrial ablation in regard to early mortality and PPMI based on the current evidence.
- 31 October 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (12) , 3039-3049
Different effects of additional ganglion plexus ablation on catheter and surgical ablation for atrial fibrillation: a systemic review and meta‐analysis
The effect of ganglion plexus (GP) ablation in addition to pulmonary veins isolation (PVI) for atrial fibrillation (AF) remained controversial between the catheter and surgical‐based studies. Eleven studies (five randomized controlled trials and six nonrandomized studies) of 1750 patients were included in a meta‐analysis to elucidate the incremental benefit of additional GP ablation in patients undergoing catheter or surgical ablation. Risk ratios were calculated for freedom from AF or AT recurrence after a single procedure. Additional GP ablation was associated with a better rhythm outcome for patients undergone catheter ablation but did not seem to increase freedom from AF/AT for surgical patients. Both paroxysmal and non‐paroxysmal AF showed a positive outcome comparing additional GP ablation with PVI alone.
- 31 October 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (12) , 3039-3049
Different effects of additional ganglion plexus ablation on catheter and surgical ablation for atrial fibrillation: a systemic review and meta‐analysis
The effect of ganglion plexus (GP) ablation in addition to pulmonary veins isolation (PVI) for atrial fibrillation (AF) remained controversial between the catheter and surgical‐based studies. Eleven studies (five randomized controlled trials and six nonrandomized studies) of 1750 patients were included in a meta‐analysis to elucidate the incremental benefit of additional GP ablation in patients undergoing catheter or surgical ablation. Risk ratios were calculated for freedom from AF or AT recurrence after a single procedure. Additional GP ablation was associated with a better rhythm outcome for patients undergone catheter ablation but did not seem to increase freedom from AF/AT for surgical patients. Both paroxysmal and non‐paroxysmal AF showed a positive outcome comparing additional GP ablation with PVI alone.